Tag: Allogene

Cell and Gene Therapy, Clinical Trials, Industry, Research and Development

Allogene starts first pivotal trials of an ‘off-the-shelf’ cell therapy for cancer

October 7, 2022

Via: Biopharma Dive

Allogene Therapeutics has begun the first pivotal test of an “off-the-shelf” cell therapy for cancer. The biotechnology company, which has been at the forefront of a push in recent years to develop such treatments, known as allogeneic therapies and derived […]

Mergers and Acquisitions

Servier cuts ties with Allogene, ending complex CAR-T partnership

September 22, 2022

Via: Biopharma Dive

French drugmaker Servier has terminated a partnership with Allogene, ending a deal whose origins began well before the high-profile developer of “off-the-shelf” cancer cell therapies was formed four years ago. A regulatory filing on Wednesday by Allogene revealed Servier’s decision […]